does pfizer have a glp-1 drug The next breakthrough in weight-loss medicine may not be stronger drug. It may simply be a people are more likely to keep taking. Pfizer's experimental obesity treatment, berobenatide, could reduce Pfizer discontinues oral GLP-1 receptor
Description
He cites that obesity and diabetes increase the risk of suicide, too
Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis
drug repurposing
GLP-1 receptor agonists are already widely used for diabetes and obesity management, and their use has increased rapidly in recent years
Regulation of muscle mass by follistatin and activins
